LPV/r 100+25mg heat/st tabs/PAC-60

Lopinavir 100mg + Ritonavir 25mg film coated heat stable tablets, bottle pack of 60
Indicative Price : Upon Request
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Lopinavir 100mg + Ritonavir 25mg film coated heat stable tablets, bottle pack of 60

Technical Specifications:
Each film coated tablet contains a fixed boosted protease inhibitor combination of Lopinavir 100mg + Ritonavir 25mg in a heat stable formulation

Therapeutic class:
Protease Inhibitors (PI)

Standard shelf life:
2 years (24 months)

Other available formulations:
LPV/r 200mg/50mg film coated heat stable tablets
LPV/r 80mg/20mg oral solution

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


WHO Essential Medicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:


WHO Generic tool for assessing paediatric ARV dosing

Management of HIV-1 infection in infected adults and children above 2 years of age in combination with at least two other antiretroviral drugs. By mouth (PO)

NOTE: Ritonavir increases effect of Lopinavir; it is used in this co-formulation as a booster to Lopinavir and this low dose in combination does not have intrinsic antiviral activity

Do not store above 30°C (86°F)
Store in tightly closed original container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack

Regulatory status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Important information regarding supply for this product

Please click on the link:
Related Products